This resolution calls on the attorney general to intensify investigations into anticompetitive practices within the healthcare industry, particularly focusing on issues such as price-fixing and market allocation. It highlights the significant disparities in pharmaceutical pricing and healthcare service costs in the state, which are often higher than those in other regions and can vary widely among patients for the same services. The resolution references previous Supreme Court rulings that affirm the applicability of antitrust laws to healthcare entities and emphasizes the growing burden of healthcare spending on the economy.

Furthermore, the resolution urges the attorney general to not only pursue enforcement actions against identified anticompetitive behaviors but also to publicly disclose the rationale behind any decisions not to take legal action. This transparency is intended to ensure accountability and adherence to the rule of law within the healthcare and pharmaceutical sectors, which are critical components of the economy, now accounting for over 20% of the gross domestic product.